NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced today that it will acquire electron microscopy firm FEI Company for $4.2 billion in cash, or $107.50 per share.

Thermo Fisher President and CEO Marc Casper said in a statement that his company will use FEI's technology to complement its existing mass spectrometry business, particularly in its work on structural proteins and biopharmaceuticals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.

Sponsored by

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.